nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—NR1I2—Rifampicin—leprosy	0.227	0.283	CbGbCtD
Paclitaxel—SLCO1B3—Rifampicin—leprosy	0.0891	0.111	CbGbCtD
Paclitaxel—ABCB11—Rifampicin—leprosy	0.0867	0.108	CbGbCtD
Paclitaxel—ABCC1—Rifampicin—leprosy	0.0616	0.0769	CbGbCtD
Paclitaxel—ABCC2—Rifampicin—leprosy	0.0456	0.0569	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0304	0.038	CbGbCtD
Paclitaxel—CYP3A7—Rifampicin—leprosy	0.0304	0.038	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0251	0.0314	CbGbCtD
Paclitaxel—CYP3A7—Dapsone—leprosy	0.0251	0.0314	CbGbCtD
Paclitaxel—CYP3A5—Thalidomide—leprosy	0.0236	0.0294	CbGbCtD
Paclitaxel—CYP3A5—Rifampicin—leprosy	0.0228	0.0285	CbGbCtD
Paclitaxel—CYP2C8—Rifampicin—leprosy	0.0219	0.0274	CbGbCtD
Paclitaxel—CYP3A5—Dapsone—leprosy	0.0188	0.0235	CbGbCtD
Paclitaxel—CYP2C8—Dapsone—leprosy	0.0181	0.0226	CbGbCtD
Paclitaxel—CYP2C9—Thalidomide—leprosy	0.0158	0.0197	CbGbCtD
Paclitaxel—CYP2C9—Rifampicin—leprosy	0.0153	0.0191	CbGbCtD
Paclitaxel—ABCB1—Rifampicin—leprosy	0.0149	0.0185	CbGbCtD
Paclitaxel—CYP2C9—Dapsone—leprosy	0.0126	0.0158	CbGbCtD
Paclitaxel—CYP3A4—Rifampicin—leprosy	0.0089	0.0111	CbGbCtD
Paclitaxel—CYP3A4—Dapsone—leprosy	0.00735	0.00917	CbGbCtD
Paclitaxel—Hypoalbuminaemia—Dapsone—leprosy	0.00532	0.0373	CcSEcCtD
Paclitaxel—Nerve injury—Dapsone—leprosy	0.00532	0.0373	CcSEcCtD
Paclitaxel—Acute myeloid leukaemia—Thalidomide—leprosy	0.00362	0.0254	CcSEcCtD
Paclitaxel—Cholangitis—Thalidomide—leprosy	0.00343	0.024	CcSEcCtD
Paclitaxel—TUBB—Menadione—Thalidomide—leprosy	0.00307	1	CbGdCrCtD
Paclitaxel—Mood alteration NOS—Thalidomide—leprosy	0.00296	0.0208	CcSEcCtD
Paclitaxel—Myelodysplastic syndrome—Thalidomide—leprosy	0.00296	0.0208	CcSEcCtD
Paclitaxel—MAP2—nerve—leprosy	0.00276	0.0624	CbGeAlD
Paclitaxel—Swelling face—Dapsone—leprosy	0.00244	0.0171	CcSEcCtD
Paclitaxel—Lymphoedema—Thalidomide—leprosy	0.00244	0.0171	CcSEcCtD
Paclitaxel—Peritonitis—Thalidomide—leprosy	0.00235	0.0165	CcSEcCtD
Paclitaxel—Tumour lysis syndrome—Thalidomide—leprosy	0.00214	0.015	CcSEcCtD
Paclitaxel—Peripheral sensory neuropathy—Thalidomide—leprosy	0.00208	0.0146	CcSEcCtD
Paclitaxel—Acute leukaemia—Thalidomide—leprosy	0.00208	0.0146	CcSEcCtD
Paclitaxel—Septic shock—Thalidomide—leprosy	0.00197	0.0138	CcSEcCtD
Paclitaxel—TUBB4B—skin epidermis—leprosy	0.00196	0.0441	CbGeAlD
Paclitaxel—Polyneuropathy—Thalidomide—leprosy	0.00182	0.0128	CcSEcCtD
Paclitaxel—Skin necrosis—Thalidomide—leprosy	0.0017	0.0119	CcSEcCtD
Paclitaxel—Intestinal perforation—Thalidomide—leprosy	0.0015	0.0105	CcSEcCtD
Paclitaxel—MAP4—eye—leprosy	0.00147	0.0331	CbGeAlD
Paclitaxel—Electrolyte imbalance—Thalidomide—leprosy	0.00142	0.00997	CcSEcCtD
Paclitaxel—Ascites—Thalidomide—leprosy	0.00131	0.00917	CcSEcCtD
Paclitaxel—Hyporeflexia—Thalidomide—leprosy	0.00131	0.00917	CcSEcCtD
Paclitaxel—Raised liver function tests—Thalidomide—leprosy	0.00129	0.00902	CcSEcCtD
Paclitaxel—MAP4—skin of body—leprosy	0.00128	0.0288	CbGeAlD
Paclitaxel—Grand mal convulsion—Thalidomide—leprosy	0.00125	0.00875	CcSEcCtD
Paclitaxel—MAPT—tendon—leprosy	0.00124	0.0279	CbGeAlD
Paclitaxel—Sinus bradycardia—Thalidomide—leprosy	0.00121	0.00849	CcSEcCtD
Paclitaxel—TUBB8—testis—leprosy	0.00118	0.0266	CbGeAlD
Paclitaxel—Transient ischaemic attack—Thalidomide—leprosy	0.00118	0.00825	CcSEcCtD
Paclitaxel—Lymphopenia—Thalidomide—leprosy	0.00116	0.00814	CcSEcCtD
Paclitaxel—BCL2—skin of body—leprosy	0.00116	0.0262	CbGeAlD
Paclitaxel—TUBB8—nervous system—leprosy	0.00116	0.0261	CbGeAlD
Paclitaxel—MAP2—eye—leprosy	0.00116	0.0261	CbGeAlD
Paclitaxel—Skin exfoliation—Dapsone—leprosy	0.00111	0.00777	CcSEcCtD
Paclitaxel—Venous thrombosis—Thalidomide—leprosy	0.0011	0.00772	CcSEcCtD
Paclitaxel—MAPT—testis—leprosy	0.00102	0.0231	CbGeAlD
Paclitaxel—Febrile neutropenia—Thalidomide—leprosy	0.000988	0.00692	CcSEcCtD
Paclitaxel—MAP4—tendon—leprosy	0.000972	0.0219	CbGeAlD
Paclitaxel—Myasthenia—Thalidomide—leprosy	0.000946	0.00663	CcSEcCtD
Paclitaxel—Hypomagnesaemia—Thalidomide—leprosy	0.000936	0.00656	CcSEcCtD
Paclitaxel—Oral candidiasis—Thalidomide—leprosy	0.000936	0.00656	CcSEcCtD
Paclitaxel—Embolism—Thalidomide—leprosy	0.000926	0.00649	CcSEcCtD
Paclitaxel—Nail disorder—Thalidomide—leprosy	0.000917	0.00642	CcSEcCtD
Paclitaxel—TUBB4A—eye—leprosy	0.000893	0.0202	CbGeAlD
Paclitaxel—Intestinal obstruction—Thalidomide—leprosy	0.000872	0.00611	CcSEcCtD
Paclitaxel—TUBB2B—eye—leprosy	0.000863	0.0195	CbGeAlD
Paclitaxel—Neuralgia—Thalidomide—leprosy	0.000856	0.006	CcSEcCtD
Paclitaxel—Thrombosis—Thalidomide—leprosy	0.00084	0.00589	CcSEcCtD
Paclitaxel—Hepatomegaly—Thalidomide—leprosy	0.00084	0.00589	CcSEcCtD
Paclitaxel—Interstitial lung disease—Thalidomide—leprosy	0.00084	0.00589	CcSEcCtD
Paclitaxel—TUBB2A—eye—leprosy	0.000812	0.0183	CbGeAlD
Paclitaxel—TUBB3—testis—leprosy	0.000804	0.0182	CbGeAlD
Paclitaxel—MAP4—testis—leprosy	0.000804	0.0182	CbGeAlD
Paclitaxel—Neuritis—Thalidomide—leprosy	0.000796	0.00558	CcSEcCtD
Paclitaxel—TUBB3—nervous system—leprosy	0.00079	0.0178	CbGeAlD
Paclitaxel—MAP4—nervous system—leprosy	0.00079	0.0178	CbGeAlD
Paclitaxel—TUBB1—testis—leprosy	0.000787	0.0178	CbGeAlD
Paclitaxel—TUBB4A—skin of body—leprosy	0.000777	0.0175	CbGeAlD
Paclitaxel—Pleural effusion—Thalidomide—leprosy	0.000777	0.00544	CcSEcCtD
Paclitaxel—TUBB1—nervous system—leprosy	0.000772	0.0174	CbGeAlD
Paclitaxel—Amblyopia—Thalidomide—leprosy	0.00077	0.00539	CcSEcCtD
Paclitaxel—MAP2—tendon—leprosy	0.000765	0.0173	CbGeAlD
Paclitaxel—Skin ulcer—Thalidomide—leprosy	0.000764	0.00535	CcSEcCtD
Paclitaxel—Hyperaesthesia—Thalidomide—leprosy	0.000758	0.00531	CcSEcCtD
Paclitaxel—Nasopharyngitis—Dapsone—leprosy	0.000754	0.00528	CcSEcCtD
Paclitaxel—Muscular weakness—Dapsone—leprosy	0.000744	0.00521	CcSEcCtD
Paclitaxel—Tingling sensation—Thalidomide—leprosy	0.00074	0.00518	CcSEcCtD
Paclitaxel—Myocardial ischaemia—Thalidomide—leprosy	0.00074	0.00518	CcSEcCtD
Paclitaxel—BCL2—testis—leprosy	0.000731	0.0165	CbGeAlD
Paclitaxel—Influenza—Dapsone—leprosy	0.000729	0.00511	CcSEcCtD
Paclitaxel—BCL2—nervous system—leprosy	0.000718	0.0162	CbGeAlD
Paclitaxel—Pancreatitis—Dapsone—leprosy	0.000715	0.00501	CcSEcCtD
Paclitaxel—Blood disorder—Thalidomide—leprosy	0.000712	0.00499	CcSEcCtD
Paclitaxel—TUBB2A—skin of body—leprosy	0.000707	0.016	CbGeAlD
Paclitaxel—TUBB6—skin of body—leprosy	0.000697	0.0157	CbGeAlD
Paclitaxel—TUBB4B—eye—leprosy	0.000696	0.0157	CbGeAlD
Paclitaxel—Sensory loss—Thalidomide—leprosy	0.000686	0.00481	CcSEcCtD
Paclitaxel—BCL2—IL2 signaling events mediated by STAT5—LTA—leprosy	0.000672	0.0771	CbGpPWpGaD
Paclitaxel—Accidental injury—Thalidomide—leprosy	0.000672	0.00471	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Dapsone—leprosy	0.000665	0.00466	CcSEcCtD
Paclitaxel—Viral infection—Thalidomide—leprosy	0.000658	0.00461	CcSEcCtD
Paclitaxel—Skin discolouration—Thalidomide—leprosy	0.000658	0.00461	CcSEcCtD
Paclitaxel—Bone disorder—Thalidomide—leprosy	0.000658	0.00461	CcSEcCtD
Paclitaxel—Cellulitis—Thalidomide—leprosy	0.000654	0.00458	CcSEcCtD
Paclitaxel—Hyperbilirubinaemia—Thalidomide—leprosy	0.000654	0.00458	CcSEcCtD
Paclitaxel—Thinking abnormal—Thalidomide—leprosy	0.00065	0.00455	CcSEcCtD
Paclitaxel—Hypocalcaemia—Thalidomide—leprosy	0.00065	0.00455	CcSEcCtD
Paclitaxel—Herpes simplex—Thalidomide—leprosy	0.000645	0.00452	CcSEcCtD
Paclitaxel—Drug interaction—Thalidomide—leprosy	0.000641	0.00449	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Dapsone—leprosy	0.000637	0.00446	CcSEcCtD
Paclitaxel—MAP2—testis—leprosy	0.000633	0.0143	CbGeAlD
Paclitaxel—Dyskinesia—Thalidomide—leprosy	0.000633	0.00443	CcSEcCtD
Paclitaxel—Hearing impaired—Thalidomide—leprosy	0.000625	0.00438	CcSEcCtD
Paclitaxel—MAP2—nervous system—leprosy	0.000622	0.014	CbGeAlD
Paclitaxel—Bone pain—Thalidomide—leprosy	0.000621	0.00435	CcSEcCtD
Paclitaxel—Atrioventricular block—Thalidomide—leprosy	0.000613	0.00429	CcSEcCtD
Paclitaxel—Sinusitis—Dapsone—leprosy	0.00061	0.00427	CcSEcCtD
Paclitaxel—Gait disturbance—Thalidomide—leprosy	0.000609	0.00427	CcSEcCtD
Paclitaxel—ABCB11—testis—leprosy	0.000607	0.0137	CbGeAlD
Paclitaxel—TUBB4B—skin of body—leprosy	0.000606	0.0137	CbGeAlD
Paclitaxel—Neck pain—Thalidomide—leprosy	0.000602	0.00422	CcSEcCtD
Paclitaxel—Pulmonary embolism—Thalidomide—leprosy	0.000595	0.00417	CcSEcCtD
Paclitaxel—Phosphatase alkaline increased—Thalidomide—leprosy	0.000595	0.00417	CcSEcCtD
Paclitaxel—TUBB4A—tendon—leprosy	0.000591	0.0133	CbGeAlD
Paclitaxel—Pharyngitis—Dapsone—leprosy	0.000579	0.00406	CcSEcCtD
Paclitaxel—TUBB2B—tendon—leprosy	0.000571	0.0129	CbGeAlD
Paclitaxel—Colitis—Thalidomide—leprosy	0.000571	0.004	CcSEcCtD
Paclitaxel—Candida infection—Thalidomide—leprosy	0.000568	0.00398	CcSEcCtD
Paclitaxel—Skin exfoliation—Thalidomide—leprosy	0.000568	0.00398	CcSEcCtD
Paclitaxel—Neuropathy—Thalidomide—leprosy	0.000558	0.00391	CcSEcCtD
Paclitaxel—CYP1B1—eye—leprosy	0.000552	0.0125	CbGeAlD
Paclitaxel—TUBB8—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.00055	0.063	CbGpPWpGaD
Paclitaxel—Dry eye—Thalidomide—leprosy	0.000549	0.00385	CcSEcCtD
Paclitaxel—Cramps of lower extremities—Thalidomide—leprosy	0.000546	0.00383	CcSEcCtD
Paclitaxel—Tinnitus—Dapsone—leprosy	0.000544	0.00381	CcSEcCtD
Paclitaxel—Oesophagitis—Thalidomide—leprosy	0.000543	0.00381	CcSEcCtD
Paclitaxel—TUBB—tendon—leprosy	0.000541	0.0122	CbGeAlD
Paclitaxel—Rash maculo-papular—Thalidomide—leprosy	0.00054	0.00379	CcSEcCtD
Paclitaxel—TUBB2A—tendon—leprosy	0.000538	0.0121	CbGeAlD
Paclitaxel—Lightheadedness—Thalidomide—leprosy	0.000532	0.00373	CcSEcCtD
Paclitaxel—TUBB6—tendon—leprosy	0.000531	0.012	CbGeAlD
Paclitaxel—Hypertonia—Thalidomide—leprosy	0.000521	0.00365	CcSEcCtD
Paclitaxel—Mental disability—Thalidomide—leprosy	0.000516	0.00361	CcSEcCtD
Paclitaxel—Sepsis—Thalidomide—leprosy	0.000516	0.00361	CcSEcCtD
Paclitaxel—Erythema—Dapsone—leprosy	0.000508	0.00356	CcSEcCtD
Paclitaxel—Thrombophlebitis—Thalidomide—leprosy	0.000499	0.00349	CcSEcCtD
Paclitaxel—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000496	0.00348	CcSEcCtD
Paclitaxel—TUBB4A—testis—leprosy	0.00049	0.0111	CbGeAlD
Paclitaxel—Deafness—Thalidomide—leprosy	0.000483	0.00338	CcSEcCtD
Paclitaxel—TUBB4A—nervous system—leprosy	0.00048	0.0108	CbGeAlD
Paclitaxel—CYP1B1—skin of body—leprosy	0.00048	0.0108	CbGeAlD
Paclitaxel—Vision blurred—Dapsone—leprosy	0.000479	0.00335	CcSEcCtD
Paclitaxel—Eye pain—Thalidomide—leprosy	0.000478	0.00335	CcSEcCtD
Paclitaxel—Cardiac failure congestive—Thalidomide—leprosy	0.000476	0.00333	CcSEcCtD
Paclitaxel—TUBB2B—testis—leprosy	0.000473	0.0107	CbGeAlD
Paclitaxel—Injury—Thalidomide—leprosy	0.00047	0.00329	CcSEcCtD
Paclitaxel—Renal failure acute—Thalidomide—leprosy	0.000468	0.00328	CcSEcCtD
Paclitaxel—ABCC10—tendon—leprosy	0.000464	0.0105	CbGeAlD
Paclitaxel—TUBB2B—nervous system—leprosy	0.000464	0.0105	CbGeAlD
Paclitaxel—TUBB4B—tendon—leprosy	0.000461	0.0104	CbGeAlD
Paclitaxel—Dermatitis exfoliative—Thalidomide—leprosy	0.000457	0.0032	CcSEcCtD
Paclitaxel—Vertigo—Dapsone—leprosy	0.000456	0.0032	CcSEcCtD
Paclitaxel—Visual disturbance—Thalidomide—leprosy	0.000455	0.00319	CcSEcCtD
Paclitaxel—Atrial fibrillation—Thalidomide—leprosy	0.000455	0.00319	CcSEcCtD
Paclitaxel—TUBB—testis—leprosy	0.000448	0.0101	CbGeAlD
Paclitaxel—TUBB2A—testis—leprosy	0.000445	0.0101	CbGeAlD
Paclitaxel—Cough—Dapsone—leprosy	0.000443	0.0031	CcSEcCtD
Paclitaxel—Cardiac failure—Thalidomide—leprosy	0.000442	0.0031	CcSEcCtD
Paclitaxel—Hypoglycaemia—Thalidomide—leprosy	0.000442	0.0031	CcSEcCtD
Paclitaxel—Lethargy—Thalidomide—leprosy	0.00044	0.00309	CcSEcCtD
Paclitaxel—Cerebrovascular accident—Thalidomide—leprosy	0.00044	0.00309	CcSEcCtD
Paclitaxel—TUBB6—testis—leprosy	0.000439	0.00992	CbGeAlD
Paclitaxel—TUBB2A—nervous system—leprosy	0.000437	0.00987	CbGeAlD
Paclitaxel—Hyponatraemia—Thalidomide—leprosy	0.000433	0.00304	CcSEcCtD
Paclitaxel—Pain in extremity—Thalidomide—leprosy	0.000432	0.00302	CcSEcCtD
Paclitaxel—TUBB6—nervous system—leprosy	0.000431	0.00973	CbGeAlD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—TNFSF15—leprosy	0.000419	0.048	CbGpPWpGaD
Paclitaxel—Cardiac arrest—Thalidomide—leprosy	0.00041	0.00288	CcSEcCtD
Paclitaxel—Mood swings—Thalidomide—leprosy	0.000409	0.00286	CcSEcCtD
Paclitaxel—Ataxia—Thalidomide—leprosy	0.000406	0.00284	CcSEcCtD
Paclitaxel—Tachycardia—Dapsone—leprosy	0.000404	0.00283	CcSEcCtD
Paclitaxel—Blood creatinine increased—Thalidomide—leprosy	0.000404	0.00283	CcSEcCtD
Paclitaxel—Dehydration—Thalidomide—leprosy	0.000401	0.00281	CcSEcCtD
Paclitaxel—Liver function test abnormal—Thalidomide—leprosy	0.000399	0.00279	CcSEcCtD
Paclitaxel—Dry skin—Thalidomide—leprosy	0.000396	0.00277	CcSEcCtD
Paclitaxel—Orthostatic hypotension—Thalidomide—leprosy	0.000394	0.00276	CcSEcCtD
Paclitaxel—Hypokalaemia—Thalidomide—leprosy	0.000393	0.00275	CcSEcCtD
Paclitaxel—Breast disorder—Thalidomide—leprosy	0.00039	0.00273	CcSEcCtD
Paclitaxel—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000389	0.00272	CcSEcCtD
Paclitaxel—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000389	0.00272	CcSEcCtD
Paclitaxel—Cramp muscle—Thalidomide—leprosy	0.000389	0.00272	CcSEcCtD
Paclitaxel—ABCC10—testis—leprosy	0.000385	0.00868	CbGeAlD
Paclitaxel—TUBB4B—testis—leprosy	0.000382	0.00862	CbGeAlD
Paclitaxel—Alanine aminotransferase increased—Thalidomide—leprosy	0.000381	0.00267	CcSEcCtD
Paclitaxel—Muscular weakness—Thalidomide—leprosy	0.000381	0.00267	CcSEcCtD
Paclitaxel—ABCB1—blood vessel—leprosy	0.000381	0.00859	CbGeAlD
Paclitaxel—Abdominal distension—Thalidomide—leprosy	0.000376	0.00263	CcSEcCtD
Paclitaxel—Insomnia—Dapsone—leprosy	0.000375	0.00263	CcSEcCtD
Paclitaxel—TUBB4B—nervous system—leprosy	0.000375	0.00846	CbGeAlD
Paclitaxel—Dysphagia—Thalidomide—leprosy	0.000373	0.00261	CcSEcCtD
Paclitaxel—Influenza—Thalidomide—leprosy	0.000373	0.00261	CcSEcCtD
Paclitaxel—ABCC2—tendon—leprosy	0.000373	0.00842	CbGeAlD
Paclitaxel—Pancreatitis—Thalidomide—leprosy	0.000366	0.00256	CcSEcCtD
Paclitaxel—CYP1B1—tendon—leprosy	0.000365	0.00825	CbGeAlD
Paclitaxel—Bronchitis—Thalidomide—leprosy	0.000359	0.00251	CcSEcCtD
Paclitaxel—Pancytopenia—Thalidomide—leprosy	0.000354	0.00248	CcSEcCtD
Paclitaxel—Neutropenia—Thalidomide—leprosy	0.000349	0.00244	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Thalidomide—leprosy	0.000347	0.00243	CcSEcCtD
Paclitaxel—Pollakiuria—Thalidomide—leprosy	0.000345	0.00241	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Thalidomide—leprosy	0.000341	0.00239	CcSEcCtD
Paclitaxel—Weight increased—Thalidomide—leprosy	0.00034	0.00238	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Dapsone—leprosy	0.000339	0.00237	CcSEcCtD
Paclitaxel—Weight decreased—Thalidomide—leprosy	0.000338	0.00236	CcSEcCtD
Paclitaxel—Hyperglycaemia—Thalidomide—leprosy	0.000337	0.00236	CcSEcCtD
Paclitaxel—Pneumonia—Thalidomide—leprosy	0.000335	0.00234	CcSEcCtD
Paclitaxel—Infestation—Thalidomide—leprosy	0.000333	0.00233	CcSEcCtD
Paclitaxel—Infestation NOS—Thalidomide—leprosy	0.000333	0.00233	CcSEcCtD
Paclitaxel—Depression—Thalidomide—leprosy	0.000332	0.00232	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00033	0.00231	CcSEcCtD
Paclitaxel—ABCC1—tendon—leprosy	0.000329	0.00742	CbGeAlD
Paclitaxel—Acute coronary syndrome—Thalidomide—leprosy	0.000328	0.0023	CcSEcCtD
Paclitaxel—Abdominal pain—Dapsone—leprosy	0.000328	0.0023	CcSEcCtD
Paclitaxel—Body temperature increased—Dapsone—leprosy	0.000328	0.0023	CcSEcCtD
Paclitaxel—Renal failure—Thalidomide—leprosy	0.000327	0.00229	CcSEcCtD
Paclitaxel—Myocardial infarction—Thalidomide—leprosy	0.000326	0.00228	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Thalidomide—leprosy	0.000326	0.00228	CcSEcCtD
Paclitaxel—Stomatitis—Thalidomide—leprosy	0.000324	0.00227	CcSEcCtD
Paclitaxel—CYP19A1—testis—leprosy	0.000324	0.0073	CbGeAlD
Paclitaxel—Conjunctivitis—Thalidomide—leprosy	0.000323	0.00227	CcSEcCtD
Paclitaxel—CYP19A1—nervous system—leprosy	0.000318	0.00717	CbGeAlD
Paclitaxel—Haematuria—Thalidomide—leprosy	0.000317	0.00222	CcSEcCtD
Paclitaxel—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—leprosy	0.000315	0.0361	CbGpPWpGaD
Paclitaxel—Epistaxis—Thalidomide—leprosy	0.000314	0.0022	CcSEcCtD
Paclitaxel—Sinusitis—Thalidomide—leprosy	0.000312	0.00219	CcSEcCtD
Paclitaxel—ABCC2—testis—leprosy	0.000309	0.00697	CbGeAlD
Paclitaxel—Bradycardia—Thalidomide—leprosy	0.000304	0.00213	CcSEcCtD
Paclitaxel—CYP1B1—testis—leprosy	0.000302	0.00683	CbGeAlD
Paclitaxel—Rhinitis—Thalidomide—leprosy	0.000299	0.0021	CcSEcCtD
Paclitaxel—Hypoaesthesia—Thalidomide—leprosy	0.000297	0.00208	CcSEcCtD
Paclitaxel—CYP1B1—nervous system—leprosy	0.000297	0.0067	CbGeAlD
Paclitaxel—Pharyngitis—Thalidomide—leprosy	0.000296	0.00208	CcSEcCtD
Paclitaxel—BCL2—Apoptosis—LTA—leprosy	0.000295	0.0338	CbGpPWpGaD
Paclitaxel—Urinary tract disorder—Thalidomide—leprosy	0.000295	0.00207	CcSEcCtD
Paclitaxel—Oedema peripheral—Thalidomide—leprosy	0.000294	0.00206	CcSEcCtD
Paclitaxel—Urethral disorder—Thalidomide—leprosy	0.000293	0.00205	CcSEcCtD
Paclitaxel—Visual impairment—Thalidomide—leprosy	0.000288	0.00202	CcSEcCtD
Paclitaxel—Erythema multiforme—Thalidomide—leprosy	0.000282	0.00198	CcSEcCtD
Paclitaxel—Eye disorder—Thalidomide—leprosy	0.000279	0.00196	CcSEcCtD
Paclitaxel—Tinnitus—Thalidomide—leprosy	0.000278	0.00195	CcSEcCtD
Paclitaxel—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.000278	0.0319	CbGpPWpGaD
Paclitaxel—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.000278	0.0319	CbGpPWpGaD
Paclitaxel—Cardiac disorder—Thalidomide—leprosy	0.000277	0.00194	CcSEcCtD
Paclitaxel—TUBB—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.000275	0.0316	CbGpPWpGaD
Paclitaxel—ABCC1—testis—leprosy	0.000272	0.00614	CbGeAlD
Paclitaxel—Angiopathy—Thalidomide—leprosy	0.000271	0.0019	CcSEcCtD
Paclitaxel—Immune system disorder—Thalidomide—leprosy	0.00027	0.00189	CcSEcCtD
Paclitaxel—Mediastinal disorder—Thalidomide—leprosy	0.000269	0.00189	CcSEcCtD
Paclitaxel—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.000268	0.0308	CbGpPWpGaD
Paclitaxel—Chills—Thalidomide—leprosy	0.000268	0.00188	CcSEcCtD
Paclitaxel—Arrhythmia—Thalidomide—leprosy	0.000267	0.00187	CcSEcCtD
Paclitaxel—Alopecia—Thalidomide—leprosy	0.000264	0.00185	CcSEcCtD
Paclitaxel—Vomiting—Dapsone—leprosy	0.000263	0.00185	CcSEcCtD
Paclitaxel—Mental disorder—Thalidomide—leprosy	0.000262	0.00183	CcSEcCtD
Paclitaxel—Malnutrition—Thalidomide—leprosy	0.00026	0.00182	CcSEcCtD
Paclitaxel—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.00026	0.0298	CbGpPWpGaD
Paclitaxel—Headache—Dapsone—leprosy	0.00026	0.00182	CcSEcCtD
Paclitaxel—Flatulence—Thalidomide—leprosy	0.000256	0.00179	CcSEcCtD
Paclitaxel—Tension—Thalidomide—leprosy	0.000255	0.00179	CcSEcCtD
Paclitaxel—Dysgeusia—Thalidomide—leprosy	0.000255	0.00178	CcSEcCtD
Paclitaxel—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.000254	0.0292	CbGpPWpGaD
Paclitaxel—Nervousness—Thalidomide—leprosy	0.000252	0.00177	CcSEcCtD
Paclitaxel—Back pain—Thalidomide—leprosy	0.000251	0.00176	CcSEcCtD
Paclitaxel—Muscle spasms—Thalidomide—leprosy	0.00025	0.00175	CcSEcCtD
Paclitaxel—Nausea—Dapsone—leprosy	0.000246	0.00172	CcSEcCtD
Paclitaxel—Vision blurred—Thalidomide—leprosy	0.000245	0.00172	CcSEcCtD
Paclitaxel—Tremor—Thalidomide—leprosy	0.000244	0.00171	CcSEcCtD
Paclitaxel—Ill-defined disorder—Thalidomide—leprosy	0.000241	0.00169	CcSEcCtD
Paclitaxel—Anaemia—Thalidomide—leprosy	0.00024	0.00168	CcSEcCtD
Paclitaxel—Agitation—Thalidomide—leprosy	0.000239	0.00167	CcSEcCtD
Paclitaxel—Angioedema—Thalidomide—leprosy	0.000238	0.00166	CcSEcCtD
Paclitaxel—Malaise—Thalidomide—leprosy	0.000234	0.00164	CcSEcCtD
Paclitaxel—Vertigo—Thalidomide—leprosy	0.000234	0.00164	CcSEcCtD
Paclitaxel—BCL2—FAS pathway and Stress induction of HSP regulation—RIPK2—leprosy	0.000233	0.0267	CbGpPWpGaD
Paclitaxel—Syncope—Thalidomide—leprosy	0.000233	0.00163	CcSEcCtD
Paclitaxel—Leukopenia—Thalidomide—leprosy	0.000233	0.00163	CcSEcCtD
Paclitaxel—CYP2C8—testis—leprosy	0.000232	0.00523	CbGeAlD
Paclitaxel—BCL2—Validated targets of C-MYC transcriptional repression—SLC11A1—leprosy	0.000231	0.0265	CbGpPWpGaD
Paclitaxel—Palpitations—Thalidomide—leprosy	0.00023	0.00161	CcSEcCtD
Paclitaxel—Loss of consciousness—Thalidomide—leprosy	0.000228	0.0016	CcSEcCtD
Paclitaxel—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.000228	0.0262	CbGpPWpGaD
Paclitaxel—Cough—Thalidomide—leprosy	0.000227	0.00159	CcSEcCtD
Paclitaxel—Convulsion—Thalidomide—leprosy	0.000225	0.00158	CcSEcCtD
Paclitaxel—ABCG2—testis—leprosy	0.000225	0.00508	CbGeAlD
Paclitaxel—Hypertension—Thalidomide—leprosy	0.000224	0.00157	CcSEcCtD
Paclitaxel—Myalgia—Thalidomide—leprosy	0.000221	0.00155	CcSEcCtD
Paclitaxel—Chest pain—Thalidomide—leprosy	0.000221	0.00155	CcSEcCtD
Paclitaxel—Arthralgia—Thalidomide—leprosy	0.000221	0.00155	CcSEcCtD
Paclitaxel—Anxiety—Thalidomide—leprosy	0.000221	0.00155	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00022	0.00154	CcSEcCtD
Paclitaxel—Discomfort—Thalidomide—leprosy	0.000219	0.00153	CcSEcCtD
Paclitaxel—Dry mouth—Thalidomide—leprosy	0.000216	0.00152	CcSEcCtD
Paclitaxel—Confusional state—Thalidomide—leprosy	0.000214	0.0015	CcSEcCtD
Paclitaxel—Oedema—Thalidomide—leprosy	0.000212	0.00149	CcSEcCtD
Paclitaxel—Infection—Thalidomide—leprosy	0.000211	0.00148	CcSEcCtD
Paclitaxel—Shock—Thalidomide—leprosy	0.000209	0.00146	CcSEcCtD
Paclitaxel—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.000209	0.0239	CbGpPWpGaD
Paclitaxel—Nervous system disorder—Thalidomide—leprosy	0.000208	0.00146	CcSEcCtD
Paclitaxel—Thrombocytopenia—Thalidomide—leprosy	0.000208	0.00146	CcSEcCtD
Paclitaxel—Tachycardia—Thalidomide—leprosy	0.000207	0.00145	CcSEcCtD
Paclitaxel—Skin disorder—Thalidomide—leprosy	0.000206	0.00144	CcSEcCtD
Paclitaxel—Hyperhidrosis—Thalidomide—leprosy	0.000205	0.00144	CcSEcCtD
Paclitaxel—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—RIPK2—leprosy	0.000203	0.0233	CbGpPWpGaD
Paclitaxel—Anorexia—Thalidomide—leprosy	0.000202	0.00142	CcSEcCtD
Paclitaxel—Hypotension—Thalidomide—leprosy	0.000198	0.00139	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Thalidomide—leprosy	0.000193	0.00135	CcSEcCtD
Paclitaxel—Insomnia—Thalidomide—leprosy	0.000192	0.00134	CcSEcCtD
Paclitaxel—Paraesthesia—Thalidomide—leprosy	0.000191	0.00133	CcSEcCtD
Paclitaxel—Dyspnoea—Thalidomide—leprosy	0.000189	0.00133	CcSEcCtD
Paclitaxel—Somnolence—Thalidomide—leprosy	0.000189	0.00132	CcSEcCtD
Paclitaxel—Dyspepsia—Thalidomide—leprosy	0.000187	0.00131	CcSEcCtD
Paclitaxel—Decreased appetite—Thalidomide—leprosy	0.000184	0.00129	CcSEcCtD
Paclitaxel—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NOD2—leprosy	0.000184	0.0211	CbGpPWpGaD
Paclitaxel—Gastrointestinal disorder—Thalidomide—leprosy	0.000183	0.00128	CcSEcCtD
Paclitaxel—Fatigue—Thalidomide—leprosy	0.000183	0.00128	CcSEcCtD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—IL10—leprosy	0.000181	0.0208	CbGpPWpGaD
Paclitaxel—Pain—Thalidomide—leprosy	0.000181	0.00127	CcSEcCtD
Paclitaxel—Constipation—Thalidomide—leprosy	0.000181	0.00127	CcSEcCtD
Paclitaxel—Feeling abnormal—Thalidomide—leprosy	0.000175	0.00122	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Thalidomide—leprosy	0.000173	0.00122	CcSEcCtD
Paclitaxel—Urticaria—Thalidomide—leprosy	0.000169	0.00118	CcSEcCtD
Paclitaxel—Abdominal pain—Thalidomide—leprosy	0.000168	0.00117	CcSEcCtD
Paclitaxel—Body temperature increased—Thalidomide—leprosy	0.000168	0.00117	CcSEcCtD
Paclitaxel—MAPT—IL-5 Signaling Pathway—IL2—leprosy	0.000158	0.0181	CbGpPWpGaD
Paclitaxel—Hypersensitivity—Thalidomide—leprosy	0.000156	0.0011	CcSEcCtD
Paclitaxel—CYP3A4—nervous system—leprosy	0.000154	0.00348	CbGeAlD
Paclitaxel—Asthenia—Thalidomide—leprosy	0.000152	0.00107	CcSEcCtD
Paclitaxel—MAPT—IL-2 Signaling Pathway—IL2—leprosy	0.000152	0.0174	CbGpPWpGaD
Paclitaxel—Pruritus—Thalidomide—leprosy	0.00015	0.00105	CcSEcCtD
Paclitaxel—Diarrhoea—Thalidomide—leprosy	0.000145	0.00102	CcSEcCtD
Paclitaxel—Dizziness—Thalidomide—leprosy	0.00014	0.000983	CcSEcCtD
Paclitaxel—Vomiting—Thalidomide—leprosy	0.000135	0.000945	CcSEcCtD
Paclitaxel—Rash—Thalidomide—leprosy	0.000134	0.000937	CcSEcCtD
Paclitaxel—Dermatitis—Thalidomide—leprosy	0.000134	0.000936	CcSEcCtD
Paclitaxel—Headache—Thalidomide—leprosy	0.000133	0.000931	CcSEcCtD
Paclitaxel—BCL2—Overview of nanoparticle effects—TNF—leprosy	0.000128	0.0147	CbGpPWpGaD
Paclitaxel—Nausea—Thalidomide—leprosy	0.000126	0.000883	CcSEcCtD
Paclitaxel—BCL2—IL2 signaling events mediated by STAT5—IL2—leprosy	0.000122	0.014	CbGpPWpGaD
Paclitaxel—ABCB1—testis—leprosy	0.000111	0.00251	CbGeAlD
Paclitaxel—ABCB1—nervous system—leprosy	0.000109	0.00246	CbGeAlD
Paclitaxel—BCL2—IL2 signaling events mediated by PI3K—IL2—leprosy	0.000103	0.0119	CbGpPWpGaD
Paclitaxel—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—leprosy	9.98e-05	0.0114	CbGpPWpGaD
Paclitaxel—BCL2—IL-5 Signaling Pathway—IL2—leprosy	9.71e-05	0.0111	CbGpPWpGaD
Paclitaxel—BCL2—IL-2 Signaling Pathway—IL2—leprosy	9.34e-05	0.0107	CbGpPWpGaD
Paclitaxel—BCL2—IL2-mediated signaling events—IFNG—leprosy	8.59e-05	0.00986	CbGpPWpGaD
Paclitaxel—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—leprosy	8.25e-05	0.00946	CbGpPWpGaD
Paclitaxel—BCL2—ATF-2 transcription factor network—IFNG—leprosy	8.01e-05	0.00918	CbGpPWpGaD
Paclitaxel—ABCC10—Transmembrane transport of small molecules—SLC11A1—leprosy	7.81e-05	0.00896	CbGpPWpGaD
Paclitaxel—BCL2—IL2-mediated signaling events—IL2—leprosy	7.64e-05	0.00876	CbGpPWpGaD
Paclitaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—leprosy	7.37e-05	0.00845	CbGpPWpGaD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—TNF—leprosy	6.91e-05	0.00792	CbGpPWpGaD
Paclitaxel—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—leprosy	6.8e-05	0.0078	CbGpPWpGaD
Paclitaxel—MAPT—Alzheimers Disease—TNF—leprosy	6.67e-05	0.00765	CbGpPWpGaD
Paclitaxel—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—leprosy	6.6e-05	0.00757	CbGpPWpGaD
Paclitaxel—BCL2—Ceramide signaling pathway—TNF—leprosy	6.11e-05	0.00701	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	5.93e-05	0.0068	CbGpPWpGaD
Paclitaxel—BCL2—C-MYB transcription factor network—CD4—leprosy	5.83e-05	0.00669	CbGpPWpGaD
Paclitaxel—BCL2—Caspase Cascade in Apoptosis—TNF—leprosy	5.33e-05	0.00611	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	5.27e-05	0.00604	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—IFNG—leprosy	5.05e-05	0.00579	CbGpPWpGaD
Paclitaxel—BCL2—Corticotropin-releasing hormone—IL2—leprosy	4.99e-05	0.00572	CbGpPWpGaD
Paclitaxel—TUBB2B—Transmembrane transport of small molecules—SLC11A1—leprosy	4.94e-05	0.00567	CbGpPWpGaD
Paclitaxel—TUBB6—Transmembrane transport of small molecules—SLC11A1—leprosy	4.94e-05	0.00567	CbGpPWpGaD
Paclitaxel—TUBB3—Transmembrane transport of small molecules—SLC11A1—leprosy	4.77e-05	0.00548	CbGpPWpGaD
Paclitaxel—TUBB2A—Transmembrane transport of small molecules—SLC11A1—leprosy	4.62e-05	0.0053	CbGpPWpGaD
Paclitaxel—TUBB1—Transmembrane transport of small molecules—SLC11A1—leprosy	4.52e-05	0.00519	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CYLD—leprosy	4.45e-05	0.0051	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—SLC11A1—leprosy	4.06e-05	0.00466	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TNF—leprosy	3.91e-05	0.00448	CbGpPWpGaD
Paclitaxel—MAPT—Apoptosis—TNF—leprosy	3.89e-05	0.00446	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—TNF—leprosy	3.84e-05	0.0044	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	3.84e-05	0.0044	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—SLC11A1—leprosy	3.71e-05	0.00426	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—TNF—leprosy	3.65e-05	0.00418	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—leprosy	3.35e-05	0.00385	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—TNF—leprosy	3.29e-05	0.00378	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—IL10—leprosy	3.22e-05	0.00369	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—CD40LG—leprosy	3.22e-05	0.00369	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—RIPK2—leprosy	2.87e-05	0.00329	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—TLR2—leprosy	2.87e-05	0.00329	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—NOD2—leprosy	2.6e-05	0.00298	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CYLD—leprosy	2.59e-05	0.00297	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—HLA-DRB1—leprosy	2.59e-05	0.00297	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—SLC11A1—leprosy	2.4e-05	0.00275	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TNF—leprosy	2.39e-05	0.00274	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—SLC11A1—leprosy	2.37e-05	0.00272	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PARK2—leprosy	2.29e-05	0.00263	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—SDHD—leprosy	2.09e-05	0.0024	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—SLC11A1—leprosy	2.09e-05	0.00239	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TNF—leprosy	2.02e-05	0.00232	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—SDHD—leprosy	1.97e-05	0.00226	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—IFNG—leprosy	1.89e-05	0.00217	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—IL2—leprosy	1.68e-05	0.00193	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—RIPK2—leprosy	1.67e-05	0.00191	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—TLR2—leprosy	1.67e-05	0.00191	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—NOD2—leprosy	1.51e-05	0.00174	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—SDHD—leprosy	1.48e-05	0.0017	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—SDHD—leprosy	1.48e-05	0.00169	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—SDHD—leprosy	1.43e-05	0.00164	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SLC11A1—leprosy	1.33e-05	0.00152	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—SDHD—leprosy	1.3e-05	0.00149	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—SDHD—leprosy	1.29e-05	0.00148	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD40LG—leprosy	1.28e-05	0.00147	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD8A—leprosy	1.27e-05	0.00145	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CD4—leprosy	1.25e-05	0.00143	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—TNF—leprosy	1.22e-05	0.0014	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	1.13e-05	0.00129	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HLA-DRB1—leprosy	1.03e-05	0.00118	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SDHD—leprosy	9.32e-06	0.00107	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SDHD—leprosy	8.07e-06	0.000926	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IFNG—leprosy	7.52e-06	0.000863	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD4—leprosy	7.27e-06	0.000833	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SDHD—leprosy	7.03e-06	0.000806	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL2—leprosy	6.69e-06	0.000767	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SDHD—leprosy	6.57e-06	0.000753	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	6.04e-06	0.000693	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SDHD—leprosy	4.33e-06	0.000497	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CD4—leprosy	4.21e-06	0.000483	CbGpPWpGaD
